ǰÑÔ
°¬×̲¡(acquired immunodeficiency syndrome,AIDS)ÔÚ1981ÄêÊ״η¢Ã÷ÓÚÃÀ¹ú£¬ËæºóÈ·¶¨Æä²¡ÔÌåΪÈËÀàÃâÒßȱÏݲ¡¶¾(human immunodeficiency virus,HIV),HIVÕ¹ÓÚ·´×ªÂ¼²¡¶¾Êô³ÉÔ±£¬ÊÇÒ»ÖÖѬȾÈËÀàÃâÒßϵͳϸ°ûµÄÂý²¡¶¾¡£²¡¶¾»ùÒò×éÓÉÁ½ÌõÏàͬµÄÕýÁ´RNA×é³É£¬È«³¤9.8kb£¬»®·Ö±àÂëGag¡¢Pol,Env½á¹¹ÂѰ׼°Tat¡¢Rev¡¢Vpu¡¢Vpr¡¢Vif¡¢NefµÈ¸¨ÖúÂѰס£HIVÓÐÁ½ÖÖѪÇåÐÍ£¬»®·ÖÊÇHIV-1ºÍHTV-2£¬×î³£¼ûµÄΪHIV-1ѬȾ¡£HIVÈö²¥Í¾¾¶Ö÷Òª°üÀ¨ÐÔÈö²¥¡¢ÑªÒºÈö²¥ºÍĸӤÈö²¥µÈ;¾¶¾ÙÐÐÈö²¥£¬Ñ¬È¾ºóÖ÷ÒªÇÖÕ¼ÃâÒßϸ°û£¬°üÀ¨Tϸ°û¡¢µ¥ºË¾ÞÊÉϸ°û¡¢Ê÷ͻ״ϸ°ûµÈ¡£Ï¸°ûÍâò±í´ïµÄCD4·Ö×ÓÊÇHIVÊÜÌ壬HIVÄÒĤÌÇÂѰ×gp120Óëϸ°ûĤÉÏCD4·Ö×ÓÍŽáºó¿Éµ¼ÖÂѬȾµÄ±¬·¢£¬AIDS»¼ÕßÁÙ´²ÌåÏÖÒÔCD4+TÁܰÍϸ°û¾ÙÐÐÐÔïÔ̺ÍÃâÒßȱÏÝÎªÌØÕ÷£¬³£°éÓÐʵÖÊÆ÷¹Ù£¨ÄÔ¡¢ÁÜͶºÏºÍ·ÎµÈ£©µÄÑ×ÐÔ¼²²¡¡¢Éñ¾ÕϰºÍ¶ñÐÔÖ×Áö¡£×ÔHIV±»·¢Ã÷ÒÔÀ´£¬¿ÆÑ§¼ÒÃǼ´×îÏÈAIDS¶¯ÎïÄ£×ÓµÄÑо¿ÊÂÇ飬СÊó¡¢Íü°·ÇÈËÁ鳤ÀදÎï¶¼ÔøÓÃÓÚAIDS¶¯ÎïÄ£×ÓµÄÑо¿¡£Æ¾Ö¤¶¯Îï¶ÔHIVµÄÃô¸ÐÐÔ¼°ÔìÄ£ÒªÁ죬AIDS¶¯ÎïÄ£×Ó·ÖΪ·ÇÈËÁ鳤ÀදÎïÄ£×Ó¡¢×ª»ùÒòСÊóÄ£×Ó¼°ÈËÔ´»¯Ð¡ÊóÄ£×Ó¡£
ÈËÔ´»¯Ð¡Êó(humanized mice)ÊÇָЯ´øÓй¦Ð§ÐÔµÄÈËÀà»ùÒò¡¢Ï¸°û»ò×éÖ¯µÄǶºÏÌåСÊ󡣸ÃÀàСÊóÓÉÓÚǶºÏÓÐÈËÀàÌØ¶¨»ùÒò£¬Õ½Ê¤ÁËͨÀýСÊ󲻿ɸ´ÖÆÄ³Ð©ÈËÀ༲²¡µÄÎó²î£¬ÊÇÈËÀ༲²¡Ä£×ÓÑо¿µÄÓÅÒ칤¾ß¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎСÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
ÃâÒßȱÏݶ¯ÎïÒÆÖ²ÈËÔìѪ¸Éϸ°û¡¢ÐØÏÙ×éÖ¯»òÍâÖÜѪϸ°ûºó¿É½¨ÉèÈËÔ´»¯Ð¡Êó¡£ÈËÍâÖÜѪÁܰÍϸ°û(peripheral blood lymphocyte,PBL)¸¹Ç»½ÓÖÖµ½SCIDСÊóºó¿ÉÖÆ±¸º¬ÈËPBLµÄÈËÔ´»¯Ð¡ÊóSCID-hu-PBL£¬Ì¥¶ùÐØÏÙ¼°Ì¥¸Îϸ°ûÒÆÖ²SCIDСÊóºó¿ÉÖÆ±¸³öº¬ÈËCD34+ÔìѪ¸Éϸ°ûºÍ³ÉÊìÁܰÍϸ°ûµÄÈËÔ´»¯Ð¡ÊóSeid-bu-Thy/Liv¡£SCIDСÊóÓë·Ç·ÊÅÖÖ¢ÌÇÄò²¡Ð¡Êó(non-obese diabetic,NOD)½»ÅäºóÐγɵÄNOD/SCIDСÊóÓе䷶µÄÐØÏÙÁܰÍÁö²¡Ñù¸Ä±ä£¬ÌåÄÚT¡¢Bϸ°û¹¦Ð§È±ÏÝ£¬NKϸ°û¹¦Ð§Ïµ÷¡£NOD/SCIDСÊóÓëIL-2ÊÜÌåγÁ´»ùÒòÇóýСÊó½»ÅäºóÐγɵÄNOD-Scid-IL2rg-/-СÊóÄÜÌá¸ßÒÆÖ²ÎïÉúÑÄÂÊ£¬NOD-Seid-IL2rg-/-СÊóÓÐÁ½ÖÖ²î±ðµÄÑÇÐÍ£ºNOGºÍNSGСÊó¡£NOGºÍNSGСÊóÊDz¡¶¾Ñ§Ñо¿ÖÐÓÅÒìµÄÄ£×Ó¶¯Îï¡£Rag2-/-IL2rg-/-ÊÇÁíÒ»ÖÖ¿ÉÓÃÓÚHIV-1ѬȾÑо¿µÄÈËÔ´»¯Ð¡Êó£¬ÖØ×鼤»î»ùÒò2 (recombination-activating gene 2, Rag2)»ùÒòȱʧºó»áµ¼ÖÂСÊóTºÍBÁܰÍϸ°û¹¦Ð§²»È«£¬Rag2-/-СÊóºÍIL2rg-/-СÊóÔÓ½»ºó±¬·¢µÄ´¿ºÏ×ÓRag2-/-IL2rg-/-СÊóTϸ°û¡¢Bϸ°ûºÍNKϸ°û¹¦Ð§Ëðʧ£¬ÏàÒËÍâÀ´ÒÆÖ²ÎïµÄÉúÑÄ£¬¿ÉÓÃ×öHIV¶¯ÎïÄ£×ÓÑо¿¡£
¹©Ìå×éÖ¯¡¢Ï¸°ûÒìÖÖÒÆÖ²¸øÃâÒßȱÏݶ¯Îïºó£¬ÒÆÖ²Îï¿ÉÔÚÃâÒßȱÏݶ¯ÎïÌåÄÚÔöÖ³¡¢À©É¢£¬ÇÒ¼á³ÖÔ¹©ÌåÒÆÖ²ÎïµÄÉúÎïѧ¹¦Ð§¡£ÓÃÓÚHIV-1Ä£×ÓÑо¿µÄÈËÔ´»¯Ð¡Ê󣬴ó¶¼Ç¶ºÏÈËÃâÒßϸ°û»òÆ÷¹Ù£¬ÈçÈËCD34+ÔìѪ¸Éϸ°û¡¢ÐØÏÙ×éÖ¯¡¢ÁܰÍϸ°û»òÌ¥¸Îϸ°ûµÈ£¬ÕâΪHIV-1²¡¶¾Ñ¬È¾ÌṩÁËÓÅÒìµÄ°ÐÆ÷¹Ù£¬ÓÐÀûÓÚHIV-1²¡¶¾ÔÚÈËÔ´»¯Ð¡ÊóÌåÄÚÔöÖ³¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
Scid-hu-Thy/LivСÊóÂé×íºó£¬ÊÖÊõÒªÁì̻¶Éö°üĤ²¿Î»ÒÆÖ²ÎHIV²¡¶¾Ö±½Ó½ÓÖÖµ½ÒÆÖ²ÎïÄÚ¸´ÖÆHIV-1ѬȾģ×Ó¡£Scid-hu-PBLС Êó¿Éͨ¹ý¸¹Ç»½ÓÖÖHIV-1µÄÒªÁ콨ÉèѬȾģ×Ó¡£ÆäËûÈËÔ´»¯Ð¡Êó´ó¶à½ÓÄɾ²Âö½ÓÖÖµÄÒªÁ콨ÉèHIV-1²¡¶¾Ñ¬È¾Ä£×Ó¡£
¡¾Ä£×ÓÌØµã¡¿£º
HIV-1²¡¶¾½ÓÖÖµ½Scid-hu-Thy/LivСÊó»úÌåÄÚÈËÒÆÖ²ÎïÖкóµ¼ÖÂCD4+Tϸ°ûÊýĿϽµ£¬ÒÆÖ²ÎïÖпɼì²âµ½¸ß²¡¶¾ÔØÁ¿¡£¸ÃÄ£×Ó¿ÉÓÃÓÚÑо¿CD4+Tϸ°ûϽµ»úÖÆºÍÆÀ¼Û¿¹²¡¶¾Ò©Îï¶Ô¼±ÐÔÆÚHIV-1ѬȾµÄ×÷Ó᣸¹Ç»½ÓÖÖHIV-1»ò½«Ñ¬È¾HIV-1µÄÈËϸ°ûÒÆÖ²¸øScid-hu-PBLСÊóºóÒýÆðСÊóCD4+Tϸ°ûÊýĿϽµ£¬ÈËPBLÖпɼì²âµ½HIV-1²¡¶¾¡£¸ÃÄ£×Ó¿ÉÓÃÓÚÑéÖ¤¿¹HIV-1 EnvÌÇÂѰ׵¥¿Ë¡¿¹ÌåµÄÖÎÁÆ×÷ÓᢻùÓÚEnvÒßÃçµÄ±£»¤×÷Óü°ÆÀ¼ÛÖÂÃôÊ÷ͻ״ϸ°û¶ÔHIV-1ѬȾµÄÖÎÁÆ×÷Óᣵ«Scid-hu-Thy/LivºÍScid-hu-PBLСÊóÄ£×Ó²»¿ÉÓÃÓÚHIV-1²¡¶¾ð¤Ä¤Í¾¾¶Èö²¥Ñо¿¡£HIV-1»òSHIV½ÓÖÖµ½NSG¡¢NOGСÊóºó£¬Ð¡ÊóѪ½¬Öпɼì²âµ½¸ßˮƽ²¡¶¾ÑªÖ¢¼°HIV-1ÌØÒìÐÔ¿¹Ì壬¶à¸öÔàÆ÷Öоù¿É¼ì²âµ½HIV-1²¡¶¾µÄ±£´æ¡£NSG¼°NOGСÊóÄ£×Ó³£ÓÃÀ´Ì½Ë÷»ùÒòÖÎÁƶÔHIV-1²¡¶¾¸´ÖƵÄÒÖÖÆ×÷Ó㬱ðµÄNSGСÊóÒ²ÊÇHIV-1ÓÕµ¼µÄÉñ¾Ö²¡ÐÔÓÅÒìÄ£×Ó¡£BLTСÊó¸¹Ç»½ÓÖÖHIV-1ºó£¬¿ÉÒ»Á¬·ºÆð¸ßˮƽ²¡¶¾ÑªÖ¢£¬CD4+Tϸ°ûÊýĿϽµ¼°±¬·¢²¡¶¾ÌØÒìÐÔµÄÌåÒººÍϸ°ûÃâÒßÓ¦´ð·´Ó¦¡£Rag2-/-IL2rg-/-СÊóͨ¹ý¸¹Ç»Í¾¾¶Ñ¬È¾HIV-1²¡¶¾ºó£¬²¡¶¾ÑªÖ¢ÔÚ¸ÃÄ£×ÓСÊó¿ÉÒ»Á¬Ò»ÄêÒÔÉÏ£¬CD4+Tϸ°ûÏÔ×ÅϽµÇÒ¶à¸ö×éÖ¯Öоù¿É¼ì²âµ½²¡¶¾µÄ±£´æ¡£
¡¾Ä£×ÓȪԴ¡¿£º
ÃÀ¹úJacksonʵÑéÊÒÌṩNSGСÊó(http: //jaxmice.jax.org/research/immunology/005557-price-intl.html)ºÍRag2-/-IL2rg-/-СÊóhttp://www.jaxmice. jax.org/strain/014593.html)¡£ÈÕ±¾ÊµÑ鶯ÎïÖÐÑëÑо¿ËùÌṩNOCСÊó(http://www.ciea.or.jp/en/nog_mouse.ntml)¡£
¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º
ÈËÔ´»¯Ð¡ÊóÒÔHIV-1²¡¶¾Ñ¬È¾ºó£¬Í¨¹ýÒÔϼ¸¸öÖ¸±ê¶ÔÄ£×Ó¾ÙÐÐÆÀ¼Û£ºÁ÷ʽϸ°ûÊõ¼ì²âÍâÖÜѪ¼°ÆäËûÆ÷¹ÙÖÐCD4+,CD8+ϸ°ûÊýÄ¿¼°CD4+/CD8+±ÈÖµ£»ÊèÉ¢ÍâÖÜѪ»òÆ÷¹ÙÖÐHIV-1²¡¶¾£¬²â¶¨Ñª½¬²¡¶¾ÔØÁ¿£¬»òͨ¹ýPCRÒªÁì¶ÔѬȾÍâÖÜѪ»òÆ÷¹ÙÖÐHIV-1 DNA¶¨Á¿£»ÊèɢѪÇ壬¼ì²â¿¹HIV-1¿¹Ì壻ÆäËûAIDSÏà¹ØÌåÕ÷£¬È縹к¡¢ÏûÊÝ¡¢Ê±»úѬȾµÈ¡£
²Î¿¼ÎÄÏ×£º
1.Akkina R. New generation humanized mice for viru research: comparalive aspecls and future prospects Virology, 2013,435 (1):14-28
2.Boberg A, Bråve A,Johansson S,el al. Murine models for HIV vaccination and challenge. Expert Rev Vacci.nes, 2008, 7 (1):117-130
3.Hatziioannou T,Evans DT. Animal models for HIV/AIDS research. Nat Rev Microbiol,2012, 10 (12): 852-867
4.Hu SL. Non-human primate models for AIDS vaccine research. Curr Drug Targets Infect Disord,2005,5 (2):193-201
5.Nischang M, Gers-Huber G, Audig é A, el al. Modeling HIV infection and therapies in humanized mice. Swis Med Wkly,2012,142:wl3618
6.van Maanen M,Sutton RE. Rodent models for HIV-1 infection and disease. Curr HlV Res, 2003, 1(1):121- 130
7.Zhang L,Su L. HTV-1 immunopathogenesis in humanized mouse models. Cell Mol Immunol, 2012, 9 (3):237-244